TY - T1的房颤预防心血管事件ter pneumonia with aspirin: one step forward, but still many to go JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.03778-2020 VL - 57 IS - 2 SP - 2003778 AU - Kolditz, Martin AU - Welte, Tobias Y1 - 2021/02/01 UR - //www.qdcxjkg.com/content/57/2/2003778.abstract N2 - Cardiovascular (CV) diseases and lower respiratory tract infections dominate human burden of disease across the world. Combined, they cause nearly 20 million or 36% of annual global deaths [1]. Additionally, both are linked together and interact bidirectionally: underlying CV disease is an established risk factor for the development of pneumonia and poor prognosis during pneumonia [2, 3], and vice versa, the role of pneumonia as risk factor for CV complications and new-onset CV disease has been demonstrated [4–6].Preventing cardiovascular events after pneumonia by aspirin: another step forward, but questions remain https://bit.ly/2H5z4OB ER -